|
Issue No. Volume 2, Issue 2 a. Wednesday, March
4, 2009 |
|
|
|
Microgen Pathogen
Notification |
The Pathogen News Letter.
This month we focus on combating pathogens
carried by rats and other rodents associated with the Bubonic plague. An
exponential increases in the general rat population in
Bangladesh and its neighbors, India and Burma have become
critical. The cause of the problem is coming from the
flowering of the bamboo forests in the Chittagong Hill Tracks, that border India and
Bangladesh. Plague is a zoonotic disease, circulating mainly among
rodents and their fleas. The bacteria Yersinia pestis is the causative agent
infecting humans. Plague then is transmitted
vis-à-vis animals-to-humans by the bite of infected fleas, via
direct contact, inhalation, and in rare circumstances, by
ingestion of infective materials. Plague can also be a very
severe disease in humans, with a case-fatality ratio of 30%-60%
if left untreated, as reported by the World Health
Organization.D-125 makes claim declarations against the
genus Yersinia.
Our goal remains to focus your attention
toward new pathogenic threats, so that you may use
Microgen-based formulations to eliminate them. We
want to thank you for your business and look forward to providing
you with only World Class Service.
Mr. Roberet G. Prince, President
Microgen, Inc. USA
www.microgeninc.com
|
|
Avian-human reassortant
influenza virus H3N2.
Influenza A (H3N2) Victoria is a reassortant strain,
meaning that its genetic material originates from different
strains that combined during a coinfection event, that is between human and
bird. Influenza viruses are known to mutate on an
approximately annual basis and have potential for pandemic
spread. H3N2 specifies the antigens present on the surface
of the virus for that particular season/strain. This
particular subtype of the flu is one of the three influenza A
subtypes responsible for seasonal flu outbreaks. The virus
can infect birds and mammals, including poultry and pigs.
During infection, the virus may exchange genetic material with
other co-infecting influenza subtypes, leading to mutations that
can precipitate pandemic outbreaks.
To request a copy of this test report, please
email Microgen, at info@microgeninc.com.
|
|
Help shape the
D-125 label.
Microgen's D-125 can be tested
on a wide range of bacterial, fungal, and viral pathogens, some
of which may be affecting your facilities. Please check the
ones of interest on the Microgen Microbial Library and we will strive
to add that pathogen to our ongoing testing queue, enabling you
to target a potential disinfection kill claim from the thousands
of pathogens in our library, so go ahead and be part of the process.
All testing requests are reviewed by our third
party specialist (Ph.D. Microbiologist) for
scientific feasibility. If a particular pathogen
cannot be tested, we may propose a surrogate
(related) microorganism or respectfully decline.
|
|
Featured Article:
Human case of swine influenza A
(H1N1), Aragon, Spain, November 2008
Read Article
D-125 kills Influenza A
(H1N1), see claim # 106.
Risk factors for sporadic
Campylobacter infection: an all-Ireland case-control study.
D-125 kills Campylobacter
ammoniagenes (Brevibacterium ammoniagenes) see claim #
45. |
|
|
